Connect with us

Finance

FDA Scientists Say Benefits of Pfizer Covid-19 Vaccine ‘clearly Outweigh’ the Risks for Children Ages 5 to 11

Published

on

Scientists at the Food and Drug Administration presented an analysis late Friday showing that the protection offered to children between the ages of 5 and 11 by the Covid vaccine developed by Pfizer and BioNTech “would clearly outweigh” the risk of myocarditis, a heart-related side effect, that the vaccine appears to cause.

The FDA’s analysis was made public ahead of a Tuesday meeting of outside scientists convened to make a recommendation on authorizing the vaccine for children in that age range. An agenda for the meeting shows sessions dedicated to the vaccine’s effectiveness, and to the potential risk of myocarditis, an inflammation of the heart. The FDA is not bound by the votes of its advisory committees, but it generally follows their advice.

Read the rest…

Source Here: statnews.com

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Finance

IndusInd Bank Rebounds After a 8-day Fall, Gains 5% on BSE

Published

on

According to a report, Hindujas are considering increasing their stake in IndusInd Bank after the Reserve Bank of India (RBI) eased ownership rules for the country’s private sector banks

Original Source: business-standard.com

Continue Reading

Finance

Macrotech Developers Rallies 6%, Hits New High on Growth Prospects

Published

on

The company plans to nearly double its pre-sales to Rs 14,000 crore by financial year 2023-24 (FY24) and further grow to Rs 20,000 crore by FY26

Original Post: business-standard.com

Continue Reading

Finance

TeamLease Services Surges 11% As Hiring Intent Highest in Q3

Published

on

The company said hiring intent has touched its zenith mark at 41 per cent in October-December quarter

Original Post: business-standard.com

Continue Reading

Trending

AggroNews.com